Pag-aaral pangklinika para sa Lupus sa Oklahoma
7 pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa mga site sa Oklahoma.
Mga Lungsod sa Oklahoma
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Oklahoma City
- Research Site, Oklahoma City
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Oklahoma Medical Research Foundation, Oklahoma City
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07409181A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
- Oklahoma Medical Research Foundation, Oklahoma City
Nagre-recruitPhase 4
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06875960A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Oklahoma Medical Research Foundation, Oklahoma City
Nagre-recruitObservasyonal na pag-aaral
Edad 16 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07175285Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Oklahoma Medical Research Foundation, Oklahoma City
Nagre-recruitPhase 3
Edad 55 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- University of Oklahoma, Oklahoma City
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978Safety of the Herpes Zoster Subunit Vaccine in Lupus
- Oklahoma Medical Research Foundation, Oklahoma City
Nagre-recruitPhase 4
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Dis 26, 2025 · NCT05559671Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.